Jay T Evans (J T Evans)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Venues

University of Montana

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Montana Jan 04 2016

United States

Director, Research Professor :: DBS

Inimmune Corporation Jan 04 2016

United States

President and CEO

GlaxoSmithKline Vaccines Oct 01 2000 - Jan 01 2016

United States

Principle Investigator :: Immunology

Publications

Viktoria Rungelrath, Mushtaq Ahmed, Linda Hicks, Shannon M Miller, Kendal T Ryter, Kyle Montgomery, George Ettenger, Alexander Riffey, Walid M Abdelwahab, Shabaana Abdul Khader, Jay T Evans
Vaccination with Mincle agonist UM-1098 and mycobacterial antigens induces protective Th1 and Th17 responses. NPJ vaccines 9 (1) (2024)
Walid M Abdelwahab, Sarah Auclair, Timothy Borgogna, Karthik Siram, Alexander Riffey, Hélène G Bazin, Howard B Cottam, Tomoko Hayashi, Jay T Evans, David J Burkhart
Co-Delivery of a Novel Lipidated TLR7/8 Agonist and Hemagglutinin-Based Influenza Antigen Using Silica Nanoparticles Promotes Enhanced Immune Responses. Pharmaceutics 16 (1) (2024)
Viktoria Rungelrath, Mushtaq Ahmed, Linda Hicks, Shannon M Miller, Kendal T Ryter, Kyle Montgomery, George Ettenger, Alexander Riffey, Walid M Abdelwahab, Shabaana Abdul Khader, Jay T Evans
Vaccination with Mincle agonist UM-1098 and mycobacterial antigens induces protective Th1 and Th17 responses. NPJ vaccines 9 (1) (2024)
Viktoria Rungelrath, Mushtaq Ahmed, Linda Hicks, Shannon M Miller, Kendal T Ryter, Kyle Montgomery, George Ettenger, Alexander Riffey, Walid M Abdelwahab, Shabaana Abdul Khader, Jay T Evans
Vaccination with Mincle agonist UM-1098 and mycobacterial antigens induces protective Th1 and Th17 responses. NPJ vaccines 9 (1) (2024)
Valery C Román-Cruz, Shannon M Miller, Roman A Schoener, Chase Lukasiewicz, Amelia K Schmidt, Blair L DeBuysscher, David Burkhart, Patrick R Secor, Jay T Evans
Adjuvanted Vaccine Induces Functional Antibodies against Pseudomonas aeruginosa Filamentous Bacteriophages. Vaccines 12 (2) (2024)
Walid M Abdelwahab, Sarah Auclair, Timothy Borgogna, Karthik Siram, Alexander Riffey, Hélène G Bazin, Howard B Cottam, Tomoko Hayashi, Jay T Evans, David J Burkhart
Co-Delivery of a Novel Lipidated TLR7/8 Agonist and Hemagglutinin-Based Influenza Antigen Using Silica Nanoparticles Promotes Enhanced Immune Responses. Pharmaceutics 16 (1) (2024)
Viktoria Rungelrath, Mushtaq Ahmed, Linda Hicks, Shannon M Miller, Kendal T Ryter, Kyle Montgomery, George Ettenger, Alexander Riffey, Walid M Abdelwahab, Shabaana Abdul Khader, Jay T Evans
Vaccination with Mincle agonist UM-1098 and mycobacterial antigens induces protective Th1 and Th17 responses. NPJ vaccines 9 (1) (2024)
Walid M Abdelwahab, Sarah Auclair, Timothy Borgogna, Karthik Siram, Alexander Riffey, Hélène G Bazin, Howard B Cottam, Tomoko Hayashi, Jay T Evans, David J Burkhart
Co-Delivery of a Novel Lipidated TLR7/8 Agonist and Hemagglutinin-Based Influenza Antigen Using Silica Nanoparticles Promotes Enhanced Immune Responses. Pharmaceutics 16 (1) (2024)
Walid M Abdelwahab, Sarah Auclair, Timothy Borgogna, Karthik Siram, Alexander Riffey, Hélène G Bazin, Howard B Cottam, Tomoko Hayashi, Jay T Evans, David J Burkhart
Co-Delivery of a Novel Lipidated TLR7/8 Agonist and Hemagglutinin-Based Influenza Antigen Using Silica Nanoparticles Promotes Enhanced Immune Responses. Pharmaceutics 16 (1) (2024)
Valery C Román-Cruz, Shannon M Miller, Roman A Schoener, Chase Lukasiewicz, Amelia K Schmidt, Blair L DeBuysscher, David Burkhart, Patrick R Secor, Jay T Evans
Adjuvanted Vaccine Induces Functional Antibodies against Pseudomonas aeruginosa Filamentous Bacteriophages. Vaccines 12 (2) (2024)
Shannon M Miller, Bethany Crouse, Linda Hicks, Hardik Amin, Shelby Cole, Helene G Bazin, David J Burkhart, Marco Pravetoni, Jay T Evans
A lipidated TLR7/8 adjuvant enhances the efficacy of a vaccine against fentanyl in mice. NPJ vaccines 8 (1) (2023)
Karthik Siram, Stephanie K Lathrop, Walid M Abdelwahab, Rebekah Tee, Clara J Davison, Haley A Partlow, Jay T Evans, David J Burkhart
Co-Delivery of Novel Synthetic TLR4 and TLR7/8 Ligands Adsorbed to Aluminum Salts Promotes Th1-Mediated Immunity against Poorly Immunogenic SARS-CoV-2 RBD. Vaccines 12 (1) (2023)
Karthik Siram, Stephanie K Lathrop, Walid M Abdelwahab, Rebekah Tee, Clara J Davison, Haley A Partlow, Jay T Evans, David J Burkhart
Co-Delivery of Novel Synthetic TLR4 and TLR7/8 Ligands Adsorbed to Aluminum Salts Promotes Th1-Mediated Immunity against Poorly Immunogenic SARS-CoV-2 RBD. Vaccines 12 (1) (2023)
Karthik Siram, Stephanie K Lathrop, Walid M Abdelwahab, Rebekah Tee, Clara J Davison, Haley A Partlow, Jay T Evans, David J Burkhart
Co-Delivery of Novel Synthetic TLR4 and TLR7/8 Ligands Adsorbed to Aluminum Salts Promotes Th1-Mediated Immunity against Poorly Immunogenic SARS-CoV-2 RBD. Vaccines 12 (1) (2023)
Karthik Siram, Stephanie K Lathrop, Walid M Abdelwahab, Rebekah Tee, Clara J Davison, Haley A Partlow, Jay T Evans, David J Burkhart
Co-Delivery of Novel Synthetic TLR4 and TLR7/8 Ligands Adsorbed to Aluminum Salts Promotes Th1-Mediated Immunity against Poorly Immunogenic SARS-CoV-2 RBD. Vaccines 12 (1) (2023)
Bethany Crouse, Shannon M Miller, Peter Muelken, Linda Hicks, Jennifer R Vigliaturo, Cheryl L Marker, Alonso G P Guedes, Paul R Pentel, Jay T Evans, Mark G LeSage, Marco Pravetoni
A TLR7/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models. NPJ vaccines 8 (1) (2023)
Karthik Siram, Stephanie K Lathrop, Walid M Abdelwahab, Rebekah Tee, Clara J Davison, Haley A Partlow, Jay T Evans, David J Burkhart
Co-Delivery of Novel Synthetic TLR4 and TLR7/8 Ligands Adsorbed to Aluminum Salts Promotes Th1-Mediated Immunity against Poorly Immunogenic SARS-CoV-2 RBD. Vaccines 12 (1) (2023)
David J Dowling, Soumik Barman, Alyson J Smith, Francesco Borriello, Danielle Chaney, Spencer E Brightman, Gandolina Melhem, Byron Brook, Manisha Menon, Dheeraj Soni, Simone Schüller, Karthik Siram, Etsuro Nanishi, Hélène G Bazin, David J Burkhart, Ofer Levy, Jay T Evans
Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination. Scientific reports 12 (1) (2022)
C J Massena, S K Lathrop, C J Davison, R Schoener, H G Bazin, Jay T Evans, D J Burkhart
A tractable covalent linker strategy for the production of immunogenic antigen-TLR7/8L bioconjugates. Chemical communications (Cambridge, England) 57 (38) (2021)
Alyson J Smith, Bridget Graves, Robert Child, Peter J Rice, Zuchao Ma, Douglas W Lowman, Harry E Ensley, Kendal T Ryter, Jay T Evans, David L Williams
Immunoregulatory Activity of the Natural Product Laminarin Varies Widely as a Result of Its Physical Properties. Journal of immunology (Baltimore, Md. : 1950) 200 (2) (2017)

Jay T Evans.css-eqlu8i{font-size:small;padding-left:4px;} (J T Evans)

Publication Activity (10 Years)

Top Topics

Top Venues

Jay T Evans (J T Evans)